(Q43264832)

English

Effect of HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors on the concentration of insulin-like growth factor-1 (IGF-1) in hypercholesterolemic patients

scientific article published in July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Effect of HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors on the concentration of insulin-like growth factor-1 (IGF-1) in hypercholesterolemic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

hypercholesterolemia

0 references

object named as

Bartosz Hudzik

3

0 references

Ewa Nowakowska-Zajdel

5

object named as

Ewa Nowakowska-Zajdel

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Janusz Szkodziński

1

object named as

Janusz Szkodziński

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Barbara Zubelewicz-Szkodzińska

8

object named as

Barbara Zubelewicz-Szkodzińska

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Andrzej Kaszuba

4

object named as

Andrzej Kaszuba

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

author name string

Wojciech Romanowski

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Ryszard Szkilnik

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Barbara Pietrasińska

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

1 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Pharmacological Reports

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

654-664

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Tumor Necrosis Factor-α Regulates Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Expression in Vascular Smooth Muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The insulin-like growth factor axis: A review of atherosclerosis and restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and cardiovascular disease risk factors in young black men and white men: the CARDIA Male Hormone Study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-like growth factor I and its binding proteins in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth hormone and insulin-like growth factor-1 in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Growth hormone and insulin-like growth factor 1 in normopituitaric patients with various degrees of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of dolichol synthesis with isoprenoids and statins may potentiate the cancer-retardant efficacy of IGF-I down-regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective tyrosine kinase inhibitor for the platelet-derived growth factor receptor in vitro inhibits smooth muscle cell proliferation after reinjury of arterial intima in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of insulin-like growth factor receptor mRNA in rabbit atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Plaque disruption and thrombosis. Potential role of inflammation and infection

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Roads to survival: insulin-like growth factor-1 signaling pathways in cardiac muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970117-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1734-1140(09)70117-3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43264832&oldid=2092318356"